Early response to bortezomib combined chemotherapy can help predict survival in patients with multiple myeloma who are ineligible for stem cell transplantation

Ho Sup Lee, Yang Soo Kim, Kihyun Kim, Jin Seok Kim, Hyo Jung Kim, Chang Ki Min, Cheolwon Suh, Hyeon Seok Eom, Sung Soo Yoon, Jae Hoon Lee, Min Kyong Kim, Sung Hyun Kim, Sung Hwa Bae, Yeung Chul Mun, Deog Yeon Jo, Joo Seop Chung

Research output: Contribution to journal › Article › peer-review

3 Scopus citations

Fingerprint

Dive into the research topics of 'Early response to bortezomib combined chemotherapy can help predict survival in patients with multiple myeloma who are ineligible for stem cell transplantation'. Together they form a unique fingerprint.

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science